Search Results - "Sandrim, Valéria C."

Refine Results
  1. 1
  2. 2
  3. 3

    Resveratrol improves endothelial cell markers impaired by plasma incubation from women who subsequently develop preeclampsia by Caldeira-Dias, Mayara, Montenegro, Marcelo F, Bettiol, Heloisa, Barbieri, Marco Antonio, Cardoso, Viviane C, Cavalli, Ricardo C, Sandrim, Valéria C

    Published in Hypertension research (01-08-2019)
    “…In this study, we demonstrated that plasma collected from women who subsequently developed preeclampsia caused increased heme oxygenase-1 (HO-1) production and…”
    Get full text
    Journal Article
  4. 4

    Amino Acid Biosignature in Plasma among Ischemic Stroke Subtypes by Resende, Rodrigo R., Pinto, Mauro C. X., Paiva, Maria J. N., Cardeal, Zenilda L., Menezes, Helvécio C., Mendes, Thiago O., Sena, Marcelo M., Goulart, Vânia A. M., Sandrim, Valéria C.

    Published in BioMed research international (01-01-2019)
    “…Ischemic stroke is a neurovascular disorder caused by reduced or blockage of blood flow to the brain, which may permanently affect motor and cognitive…”
    Get full text
    Journal Article
  5. 5

    Higher levels of circulating TIMP-4 in preeclampsia is strongly associated with clinical parameters and microRNA by Sandrim, Valéria C., Diniz, Solange, Eleuterio, Nibia Mariana, Gomes, Karina B., Dusse, Luci Maria S., Cavalli, Ricardo C.

    “…Background: Preeclampsia results in maternal and fetal complications and some studies have reported the role of MMPs and TIMPs in its pathophysiology…”
    Get full text
    Journal Article
  6. 6

    Polymorphisms in endothelial nitric oxide synthase gene in early and late severe preeclampsia by Alpoim, Patrícia Nessralla, Gomes, Karina Braga, Pinheiro, Melina de Barros, Godoi, Lara Carvalho, Jardim, Letícia Lemos, Muniz, Ludmila Gomes, Sandrim, Valéria C., Fernandes, Ana Paula, Dusse, Luci Maria S.

    Published in Nitric oxide (15-11-2014)
    “…•NO pathway seems to play a central role in uteroplacental changes during pregnancy.•Preeclampsia (PE) is associated with endothelial dysfunction.•Polymorphism…”
    Get full text
    Journal Article
  7. 7

    4G/5G polymorphism modulates PAI-1 circulating levels in obese women by Fernandes, Karla S., Sandrim, Valéria C.

    Published in Molecular and cellular biochemistry (01-05-2012)
    “…The increase in plasminogen activator inhibitor type 1 (PAI-1) has been described as a risk factor to thrombosis-related diseases. In addition, it has been…”
    Get full text
    Journal Article
  8. 8

    Endogenous nitric oxide formation correlates negatively with circulating matrix metalloproteinase (MMP)-2 and MMP-9 levels in black subjects by Metzger, Ingrid F., Sandrim, Valéria C., Tanus-Santos, Jose E.

    Published in Molecular and cellular biochemistry (01-01-2012)
    “…Deficient formation of endogenous nitric oxide (NO) contributes to cardiovascular diseases, and this may be associated with increased circulating levels of…”
    Get full text
    Journal Article
  9. 9

    Antihypertensive therapy in pre-eclampsia: effects of plasma from nonresponsive patients on endothelial gene expression by Luizon, Marcelo R, Caldeira-Dias, Mayara, Deffune, Elenice, Fernandes, Karla S, Cavalli, Ricardo C, Tanus-Santos, José E, Sandrim, Valéria C

    Published in Pharmacogenomics (01-07-2016)
    “…Over 40% of patients with pre-eclampsia are nonresponsive to antihypertensive therapy, but the underlying mechanisms are unknown. We examined the effects of…”
    Get full text
    Journal Article
  10. 10
  11. 11

    NAMPT levels are inversely related to nitric oxide formation and positively related to soluble fms-like tyrosine kinase-1 levels in preeclampsia by Pereira, Daniela A., Sandrim, Valéria C., Palei, Ana C.T., Tanus-Santos, Jose E., Belo, Vanessa A., Cavalli, Ricardo C., Luizon, Marcelo R.

    Published in Pregnancy hypertension (01-10-2019)
    “…•Plasma NAMPT and nitrite levels are positively related in healthy pregnant.•Plasma NAMPT and nitrite levels are inversely related in preeclampsia.•Plasma…”
    Get full text
    Journal Article
  12. 12

    Homocysteine and nitrite levels are modulated by MTHFR 677C>T polymorphism in obese women treated with simvastatin by Villela, Maria P, Andrade, Vanessa L, Eccard, Bryelle, Jordão, Alceu A, Sertório, Jonas T, Tanus-Santos, Jose E, Silva, Ieda FO, Silveira, Josianne N, Sandrim, Valéria C

    “…Summary Higher homocysteine (Hcy) levels are associated with cardiovascular risk. The aim of the present study was to evaluate the effect of simvastatin…”
    Get full text
    Journal Article
  13. 13

    Anti-inflammatory effects of atorvastatin: Modulation by the T-786C polymorphism in the endothelial nitric oxide synthase gene by Souza-Costa, Débora C, Sandrim, Valéria C, Lopes, Lívia F, Gerlach, Raquel F, Rego, Eduardo M, Tanus-Santos, Jose E

    Published in Atherosclerosis (01-08-2007)
    “…Abstract Statins produce cholesterol-independent, anti-inflammatory effects, which result at least in part from increased endothelial nitric oxide production…”
    Get full text
    Journal Article
  14. 14

    Endothelial nitric oxide synthase haplotypes affect the susceptibility to hypertension in patients with type 2 diabetes mellitus by Sandrim, Valéria C., de Syllos, Roger W.C., Lisboa, Hugo R.K., Tres, Glaucia S., Tanus-Santos, Jose E.

    Published in Atherosclerosis (01-11-2006)
    “…Type 2 diabetes mellitus (T2DM) and hypertension (HT) commonly coexist. While endothelial nitric oxide synthase (eNOS) haplotypes have been associated with HT,…”
    Get full text
    Journal Article
  15. 15

    Endothelial nitric oxide synthase haplotypes are related to blood pressure elevation, but not to resistance to antihypertensive drug therapy by Sandrim, Valéria C, Yugar-Toledo, Juan C, Desta, Zeruesenay, Flockhart, David A, Moreno, Heitor, Tanus-Santos, Jose E

    Published in Journal of hypertension (01-12-2006)
    “…OBJECTIVESMost hypertensive patients require two or more drugs to control arterial blood pressure effectively. Although endothelial nitric oxide synthase…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18

    Different Proteomic Profiles Regarding Antihypertensive Therapy in Preeclampsia Pregnant by Pinto-Souza, Caroline C, Kaihara, Julyane N S, Nunes, Priscila R, Mastella, Moises H, Rossini, Bruno C, Cavecci-Mendonça, Bruna, Cavalli, Ricardo de Carvalho, Dos Santos, Lucilene D, Sandrim, Valeria C

    “…Preeclampsia (PE) is a hypertensive pregnancy syndrome associated with target organ damage and increased cardiovascular risks, necessitating antihypertensive…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Pharmacogenomics of Hypertension and Preeclampsia: Focus on Gene-Gene Interactions by Luizon, Marcelo R, Pereira, Daniela A, Sandrim, Valeria C

    Published in Frontiers in pharmacology (28-02-2018)
    “…Hypertension is a leading cause of cardiovascular mortality, but only about half of patients on antihypertensive therapy achieve blood pressure control…”
    Get full text
    Journal Article